Clinical Trial Update: Renal Mechanism of Action/Splay vs. TmG [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a renal mechanism of action comparing Splay and TmG in diabetes mellitus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes, NOS | Phase 1 | Status: TERMINATED